Vereinigte Staaten von Amerika Continuous Glucose Monitoring Market GRÖSSEN- UND MARKTANTEILSANALYSE - WACHSTUMSTRENDS UND PROGNOSEN (2024 - 2031)

Vereinigte Staaten von Amerika Continuous Glucose Monitoring Market wird von Komponenten (Sensoren, Transmitters & Receivers, Integrated System, Others), By Demographic (Adults (18-65), Geriatrics (65+), Kinder- und Jugendliche), By Indication (Type 1 Diabetes, Gestational Diabetes, Typ 2 Diabetes, Andere), By End-User (Hospital Clinics, Home Cares, Home Der Bericht bietet den Wert (in Mrd. USD) für die oben genannten Segmente.

Competitive overview of United States of America Continuous Glucose Monitoring Market

Zu den wichtigsten Akteuren in den Vereinigten Staaten von Amerika Continuous Glucose Monitoring Market gehören Abbott, Dexcom, Inc., Medtronic, Senseonics, Inc., F. Hoffmann-La Roche Ltd., GLUCOVATION, INC., Nemaura Medical Inc., GlySens, GlucoModicum und Signos, Inc.

United States of America Continuous Glucose Monitoring Market Leaders

  • Abb.
  • Dexcom, Inc.
  • Medtronic
  • Senseonics, Inc.
  • F. Hoffmann-La Roche Ltd.
*Disclaimer: Major players are listed in no particular order.

United States of America Continuous Glucose Monitoring Market - Competitive Rivalry, 2023

Market Concentration Graph

United States of America Continuous Glucose Monitoring Market

Market Consolidated
(Dominated by major players)
Market Fragmented
(Highly competitive with lots of players.)
*Source: Coherent Market Insights